All News

    Reassessing Immunotherapy Use in Advanced Renal Cell Carcinoma

    April 18th 2025, 9:00pm

    Article

    There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting.

    Recognizing Symptoms During Head and Neck Cancer Awareness Month

    April 18th 2025, 8:00pm

    Video

    Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of the disease to be aware of.

    AI Tool May Better Predict Transplant Risk in Myelofibrosis

    April 18th 2025, 7:00pm

    Article

    An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an expert.

    Daffodils and Determination from a Patient with Chronic Lymphocytic Leukemia

    April 18th 2025, 5:00pm

    Article

    Each spring, I find strength and hope in the daffodils I grow, helping me face chronic lymphocytic leukemia with renewed determination.

    First Patient Dosed in a Phase 1/2 Trial for Small Cell Lung Cancer

    April 18th 2025, 4:00pm

    Article

    The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus immune checkpoint inhibitors.

    First Patient with Colon Cancer Dosed in a Phase 2 Study of TCMCB07

    April 18th 2025, 3:00pm

    Article

    The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal cancer undergoing chemotherapy.

    Radiation Delay in NSCLC May Aid Outcomes, But Raises Toxicity Risks

    April 18th 2025, 1:00pm

    Article

    Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks.

    Radiation Therapy Now More Targeted and Tolerable in GI Cancer

    April 17th 2025, 9:00pm

    Article

    Radiation therapy for gastrointestinal cancers is more precise and easier to tolerate due newer technologies and personalized care, according to experts.

    Dr. Grivas Highlights Three Practice-Changing Trials in Bladder Cancer

    April 17th 2025, 8:00pm

    Video

    Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three practice-changing phase 3 trials.

    Antibody-Drug Conjugates Changed the Standard of Care in Bladder Cancer

    April 17th 2025, 7:00pm

    Article

    Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, replacing single-agent treatments.